Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Azilsartan Medoxomil vs Ramipril in Essential Hypertension
NCT00760214Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Jan 2008; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00760214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00760214.